| Developmental dysplasia of the hip in the newborn: A systematic review V Gulati, K Eseonu, J Sayani, N Ismail, C Uzoigwe, MZ Choudhury, ... World journal of orthopedics 4 (2), 32, 2013 | 212* | 2013 |
| Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation IA Voutsadakis Journal of clinical medicine 5 (1), 11, 2016 | 105 | 2016 |
| Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin–proteasome system and Cox‐2 IA Voutsadakis Journal of cellular and molecular medicine 11 (2), 252-285, 2007 | 93 | 2007 |
| The ubiquitin–proteasome system and signal transduction pathways regulating epithelial mesenchymal transition of cancer IA Voutsadakis Journal of biomedical science 19, 1-13, 2012 | 92 | 2012 |
| The ubiquitin-proteasome system in colorectal cancer IA Voutsadakis Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1782 (12 …, 2008 | 91 | 2008 |
| Breast sarcomas: current and future perspectives IA Voutsadakis, K Zaman, S Leyvraz The Breast 20 (3), 199-204, 2011 | 90 | 2011 |
| Molecular predictors of gemcitabine response in pancreatic cancer IA Voutsadakis World journal of gastrointestinal oncology 3 (11), 153, 2011 | 88 | 2011 |
| Thrombocytosis as a prognostic marker in gastrointestinal cancers IA Voutsadakis World journal of gastrointestinal oncology 6 (2), 34, 2014 | 86 | 2014 |
| Proteasome expression and activity in cancer and cancer stem cells IA Voutsadakis Tumor Biology 39 (3), 1010428317692248, 2017 | 81 | 2017 |
| Apoptosis and the pathogenesis of lymphoma IA Voutsadakis Acta oncologica 39 (2), 151-156, 2000 | 77 | 2000 |
| FOLFIRINOX chemotherapy in metastatic pancreatic cancer: a systematic review and meta-analysis of retrospective and phase II studies S Thibodeau, IA Voutsadakis Journal of clinical medicine 7 (1), 7, 2018 | 59 | 2018 |
| Vitamin D baseline levels at diagnosis of breast cancer: A systematic review and meta-analysis IA Voutsadakis Hematology/oncology and stem cell therapy 14 (1), 16-26, 2021 | 58 | 2021 |
| Immune blockade inhibition in breast cancer IA Voutsadakis Anticancer research 36 (11), 5607-5622, 2016 | 56 | 2016 |
| Hormone receptors in serous ovarian carcinoma: prognosis, pathogenesis, and treatment considerations IA Voutsadakis Clinical Medicine Insights: Oncology 10, CMO. S32813, 2016 | 56 | 2016 |
| Orbital metastasis of breast carcinoma PJ Vlachostergios, IA Voutsadakis, CN Papandreou Breast cáncer: basic and clinical research 3, 117822340900300001, 2009 | 53 | 2009 |
| Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancer A Stravodimou, IA Voutsadakis International journal of breast cancer 2013 (1), 289563, 2013 | 50 | 2013 |
| Ubiquitination and the Ubiquitin–Proteasome System as regulators of transcription and transcription factorsin epithelial mesenchymal transition of cancer IA Voutsadakis Tumor Biology 33 (4), 897-910, 2012 | 50 | 2012 |
| Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis IA Voutsadakis Journal of Cancer Research and Clinical Oncology 133 (12), 917-928, 2007 | 50 | 2007 |
| NK cells in allogeneic bone marrow transplantation IA Voutsadakis Cancer Immunology, Immunotherapy 52 (9), 525-534, 2003 | 49 | 2003 |
| The chemosensitivity of testicular germ cell tumors IA Voutsadakis Cellular oncology 37 (2), 79-94, 2014 | 47 | 2014 |
